Table 2.
Patients’ classification according to their disease
| Grouped by disease | ||||||||
|---|---|---|---|---|---|---|---|---|
| Missing | CANOMAD | CIDP | Hereditary neuropathy | IgM-MGUS | AN | Controls | p value | |
| N (%) | 3 (3.8) | 37 (46.8) | 11 (13.9) | 21 (26.5) | 7 (8.9) | 50 | ||
| Age (years), mean (SD) | 0 | 72.2 (9.4) | 59.5 (10.4) | 54.5 (15.3) | 67.1 (9.3) | 57.7 (21.4) | 59.9 (9.4) | 0.015 |
| Sex, male (%) | 2 (66.7) | 20 (54.1) | 4 (36.4) | 19 (90.5) | 6 (85.7) | 17 (34.0) | ||
| 2 MWT distance (m), mean (SD) | 0 | 109.3 (11.4) | 127.1 (44.3) | 117.5 (43.6) | 147.0 (27.5) | 127.7 (42.8) | 198.0 (35.3) | < 0.001 |
| Vigorimeter, mean (SD) | ||||||||
| Left | 0 | 53.3 (25.2) | 62.8 (25.6) | 65.7 (25.6) | 80.8 (26.4) | 71.4 (20.6) | NA | |
| Right | 0 | 46.0 (24.2) | 61.4 (22.8) | 62.2 (24.2) | 79.4 (22.8) | 70.6 (20.3) | NA | |
| MRCss total, mean (SD) | 0 | 58.3 (1.5) | 57.5 (3.0) | 56.1 (3.9) | 59.0 (1.8) | 56.7 (3.7) | NA | NA |
| INCAT total, mean (SD) | 1 | 2.3 (1.4) | 2.4 (1.4) | 2.4 (1.6) | 1.4 (1.2) | 1.9 (1.5) | NA | NA |
| iRODS total, mean (SD) | 8 | 35.0 (4.2) | 35.1 (7.7) | 35.8 (9.3) | 40.6 (5.7) | 40.4 (8.3) | NA | NA |
Number, mean, standard deviation (sd) of patients included of each pathology according to age and sex. Mean and sd results of 2-min-walking-test (2MWT), grip strength using vigorimeter, Medical Research Council sum score (MRCss), Inflammatory Neuropathy Cause and Treatment (INCAT), Inflammatory Rasch-built Overall Disability Scale (iRODS). NA refers to not applicable in that specific variable. Chi-quadrat test used for study the differences between sex and ANOVA test used to analyze the differences between controls and patients in 2MWT
CANOMAD chronic ataxic neuropathy, ophthalmoplegia, immunoglobulin M [IgM] paraprotein, cold agglutinins, and disialosyl antibodies; CIDP chronic inflammatory demyelinating polyneuropathy; IgM-MGUS monoclonal gammopathy of undetermined significance associated with IgM; AN autoimmune nodopathy